Lampa, Angel B.
HRN: 21-11-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/20/2022
07/26/2022
IV
540mg
Q8Hrs
PCAP-C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes